Daylight Medical announced that it has sold its UVC disinfection business to Sealed Air’s Diversey Care.
The financial details of the deal were not disclosed.
Included in the deal are Daylight Medical’s MoonBeam3 disinfection system, SKY 6Xi and 7Xi devices. The devices are designed to disinfect patient rooms, surfaces, non-critical equipment and devices. By using UVC light, the devices can quickly and effectively kill pathogens like bacteria and C. difficile.
“Daylight Medical’s UVC technology is game-changing, bringing ease of use and effectiveness together with a total lower cost that enables facilities to incorporate these devices into daily cleaning and disinfection protocols quickly and easily,” said Peter O. Botten, owner of Daylight Medical, in a press release. “Incorporating Daylight’s technology into Diversey’s portfolio of leading infection prevention solutions will quickly ramp up their use in facilities across the globe. Helping create safer environments has always been our goal, and we’re excited to see that fast-tracked by partnering with Diversey.”
The MoonBeam3 is a portable device for area, room and non-critical equipment disinfection. Pathogens, viruses, bacteria and spores are reduced up to a 3- to 6-log. It has 3 articulating arms that optimize UVC dose delivery.
SKY 6Xi and 7Xi disinfect phones and tablet to decrease the risk of infection through hospital staff, visitors and patients.
“When combined with consistent and proper manual cleaning and disinfection, UVC disinfection technology has the power to reduce the spread of pathogens that can cause dangerous infections,” said Dr. Iham Kadri, president of Diversey Care. “Daylight’s innovations are a synergistic fit with our existing infection prevention platform. Adjunct technologies, such as these no-touch disinfection devices, will allow all facilities concerned with preventing infection, from hospitals to schools to airports, to add an additional level of assurance to their existing protocols.”
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]